<VariationArchive VariationID="418218" VariationName="NM_001369369.1(FOXN1):c.1201_1216del (p.Pro401fs)" VariationType="Deletion" Accession="VCV000418218" Version="11" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-28" DateCreated="2017-04-27" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="409857" VariationID="418218">
      <GeneList>
        <Gene Symbol="FOXN1" FullName="forkhead box N1" GeneID="8456" HGNC_ID="HGNC:12765" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="28506348" stop="28538900" display_start="28506348" display_stop="28538900" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="26850958" stop="26865174" display_start="26850958" display_stop="26865174" Strand="+" />
          </Location>
          <OMIM>600838</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001369369.1(FOXN1):c.1201_1216del (p.Pro401fs)</Name>
      <CanonicalSPDI>NC_000017.11:28534758:CCTGGGCTGTCCGCCCCCTGGGCTGTCCG:CCTGGGCTGTCCG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="28534759" stop="28534774" display_start="28534759" display_stop="28534774" variantLength="16" positionVCF="28534758" referenceAlleleVCF="TCCTGGGCTGTCCGCCC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="26861777" stop="26861792" display_start="26861777" display_stop="26861792" variantLength="16" positionVCF="26861776" referenceAlleleVCF="TCCTGGGCTGTCCGCCC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>P401fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003593.2" sequenceAccession="NM_003593" sequenceVersion="2" change="c.1201_1216delCCCCCTGGGCTGTCCG">
            <Expression>NM_003593.2:c.1201_1216delCCCCCTGGGCTGTCCG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.28534772_28534787del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.28534772_28534787del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003593.3" sequenceAccession="NM_003593" sequenceVersion="3" change="c.1201_1216del">
            <Expression>NM_003593.3:c.1201_1216del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003584.2" sequenceAccession="NP_003584" sequenceVersion="2" change="p.Pro401fs">
            <Expression>NP_003584.2:p.Pro401fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007260.1" sequenceAccession="NG_007260" sequenceVersion="1" change="g.15832_15847del">
            <Expression>NG_007260.1:g.15832_15847del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.26861790_26861805del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.26861790_26861805del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369369.1" sequenceAccession="NM_001369369" sequenceVersion="1" change="c.1201_1216del" MANESelect="true">
            <Expression>NM_001369369.1:c.1201_1216del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356298.1" sequenceAccession="NP_001356298" sequenceVersion="1" change="p.Pro401fs">
            <Expression>NP_001356298.1:p.Pro401fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_61" sequenceAccession="LRG_61">
            <Expression>LRG_61:g.15832_15847del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_61t1" sequenceAccession="LRG_61t1">
            <Expression>LRG_61t1:c.1201_1216del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_61p1" sequenceAccession="LRG_61p1" change="p.Pro401fs">
            <Expression>LRG_61p1:p.Pro401fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003593.2" sequenceAccession="NM_003593" sequenceVersion="2" change="c.1201_1216del16">
            <Expression>NM_003593.2:c.1201_1216del16</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16620352" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="600838.0007" DB="OMIM" />
        <XRef Type="rs" ID="1064793129" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001369369.1(FOXN1):c.1201_1216del (p.Pro401fs) AND not provided" Accession="RCV000480423" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-06-19" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001369369.1(FOXN1):c.1201_1216del (p.Pro401fs) AND T-cell immunodeficiency, congenital alopecia, and nail dystrophy" Accession="RCV000555732" Version="7">
        <ClassifiedConditionList TraitSetID="2412">
          <ClassifiedCondition DB="MedGen" ID="C1866426">T-cell immunodeficiency, congenital alopecia, and nail dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001369369.1(FOXN1):c.1201_1216del (p.Pro401fs) AND T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant" Accession="RCV001027396" Version="3">
        <ClassifiedConditionList TraitSetID="52870">
          <ClassifiedCondition DB="MedGen" ID="C5394133">T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-11-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-17" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-04-27" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">31447097</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31566583</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-01-30">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-12-26">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="52870" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="43763" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant</ElementValue>
                <XRef ID="MONDO:0032928" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">TLIND</ElementValue>
                <XRef Type="MIM" ID="618806" DB="OMIM" />
              </Symbol>
              <XRef ID="C5394133" DB="MedGen" />
              <XRef ID="MONDO:0032928" DB="MONDO" />
              <XRef Type="MIM" ID="618806" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2412" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4527" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Congenital alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pignata Guarino syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">T-cell immunodeficiency, congenital alopecia, and nail dystrophy</ElementValue>
                <XRef ID="MONDO:0011132" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4358" />
                <XRef ID="4358" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="169095" DB="Orphanet" />
              <XRef ID="C1866426" DB="MedGen" />
              <XRef ID="MONDO:0011132" DB="MONDO" />
              <XRef Type="MIM" ID="601705" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1100125" SubmissionDate="2019-01-29" DateLastUpdated="2017-04-27" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDX:22930|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000565018" DateUpdated="2017-04-27" DateCreated="2017-04-27" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-06-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.1201_1216del16 variant in the FOXN1 gene has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. However, GeneDx has observed this variant as a de novo heterozygous variant (without a second identifiable FOXN1 variant) in another individual referred for exome analysis. The c.1201_1216del16 variant causes a frameshift starting with codon Proline 401, changes this amino acid to an Alanine residue and creates a premature Stop codon at position 144 of the new reading frame, denoted p.Pro401AlafsX144. This variant is predicted to replace the last 248 amino acids of the protein with 143 incorrect amino acids. The c.1201_1216del16 variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003593.2:c.1201_1216del16</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1237864" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="2112951|MedGen:C1866426" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000645325" DateUpdated="2024-02-20" DateCreated="2017-12-26" Type="SCV" Version="7" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31447097</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31566583</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31566583</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31566583</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro401Alafs*144) in the FOXN1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 248 amino acid(s) of the FOXN1 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with FOXN1 haploinsufficiency (PMID: 31447097, 31566583; Invitae). ClinVar contains an entry for this variant (Variation ID: 418218). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects FOXN1 function (PMID: 31566583). This variant disrupts a region of the FOXN1 protein in which other variant(s) (p.Gln489Argfs*61) have been determined to be pathogenic (PMID: 31566583). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.26861777_26861792del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1866426" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2329933" SubmissionDate="2020-11-11" DateLastUpdated="2020-11-14" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="600838.0007_T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT" title="FOXN1, 16-BP DEL, NT1201_T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT" />
        <ClinVarAccession Accession="SCV001189943" DateUpdated="2020-11-14" DateCreated="2020-03-16" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-11-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 5 unrelated children (P9 to P13) and 2 of their parents (P26 and P29) with autosomal dominant infantile T-cell lymphopenia with or without nail dystrophy (TLIND; 618806), Bosticardo et al. (2019) identified a heterozygous 16-bp deletion (c.1201_1216del16, NM_003593) in the FOXN1 gene, resulting in a frameshift and premature termination (Pro401AlafsTer144). The mutation, which was found by targeted sequencing of genes involved in immunodeficiency, was not found in the gnomAD database. Functional studies of the variant and studies of patient cells were not performed, but the variant was predicted to result in haploinsufficiency. The pediatric patients, who were identified through newborn screening for SCID, had mild variable features, including absent thymic shadow (in 2), nail dystrophy (in 1), recurrent upper respiratory infections (in 1), and atopic dermatitis/eczema (in 3). One adult patient had nail dystrophy and the other had recurrent otitis and pneumonia.</Attribute>
              <Citation>
                <ID Source="PubMed">31447097</ID>
              </Citation>
              <XRef DB="OMIM" ID="618806" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXN1" />
          </GeneList>
          <Name>FOXN1, 16-BP DEL, NT1201</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">16-BP DEL, NT1201</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600838.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1237864" TraitType="Disease" MappingType="XRef" MappingValue="C1866426" MappingRef="MedGen">
        <MedGen CUI="C1866426" Name="T-cell immunodeficiency, congenital alopecia, and nail dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2329933" TraitType="Disease" MappingType="Name" MappingValue="T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT" MappingRef="Preferred">
        <MedGen CUI="C5394133" Name="T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1100125" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

